Loading...
Market
What will be the most reported side effect of the Japanese tooth regrowth drug by 2025?
2
Resolution / Starting Odds
Mild discomfort • 25%
Gum irritation • 25%
Severe pain • 25%
No significant side effects • 25%
Clinical trial reports and publications
Story
Japanese Drug Aims to Regrow Teeth by Targeting USAG-1 Protein
Dec 14, 2024, 06:00 AM
Japanese researchers are testing a pioneering drug aimed at regrowing teeth by targeting the USAG-1 protein, potentially offering an alternative to dentures and implants. Clinical trials began in October at Kyoto University Hospital, with the drug being administered to adults who have lost at least one tooth. The treatment has shown promising results in animal testing, including mice and ferrets. The research, led by Katsu Takahashi from the Medical Research Institute Kitano Hospital in Osaka, aims to make the drug available for children by 2030, focusing initially on those with congenital conditions causing tooth loss.
View original story
Similar markets
Yes • 50%
No • 50%
Yes • 50%
No • 50%
Safety concerns • 25%
Efficacy issues • 25%
Regulatory hurdles • 25%
Other • 25%
Dental implants alternative • 25%
Cosmetic dentistry • 25%
Orthodontic applications • 25%
Other • 25%
Yes • 50%
No • 50%
Japan • 25%
United States • 25%
European Union • 25%
Other • 25%
No reports • 25%
Mild side effects • 25%
Moderate side effects • 25%
Severe side effects • 25%
Mild side effects • 25%
Moderate side effects • 25%
Severe side effects • 25%
No significant side effects • 25%
Significant drop in sales • 25%
Moderate drop in sales • 25%
No significant impact • 25%
Increase in sales • 25%
No significant impact • 25%
Slight decrease in sales • 25%
Significant decrease in sales • 25%
Brand boycott • 25%
Increased lifespan • 25%
Improved healthspan • 25%
Reduced inflammation • 25%
Other • 25%
Nausea • 25%
Fatigue • 25%
Diarrhea • 25%
Other • 25%